1. Home
  2. LEE vs CTSO Comparison

LEE vs CTSO Comparison

Compare LEE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • CTSO
  • Stock Information
  • Founded
  • LEE 1890
  • CTSO 1997
  • Country
  • LEE United States
  • CTSO United States
  • Employees
  • LEE N/A
  • CTSO N/A
  • Industry
  • LEE Newspapers/Magazines
  • CTSO Medical/Dental Instruments
  • Sector
  • LEE Consumer Discretionary
  • CTSO Health Care
  • Exchange
  • LEE Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • LEE 52.4M
  • CTSO 52.6M
  • IPO Year
  • LEE N/A
  • CTSO N/A
  • Fundamental
  • Price
  • LEE $6.30
  • CTSO $1.18
  • Analyst Decision
  • LEE
  • CTSO Buy
  • Analyst Count
  • LEE 0
  • CTSO 2
  • Target Price
  • LEE N/A
  • CTSO $5.50
  • AVG Volume (30 Days)
  • LEE 18.0K
  • CTSO 99.9K
  • Earning Date
  • LEE 07-31-2025
  • CTSO 08-12-2025
  • Dividend Yield
  • LEE N/A
  • CTSO N/A
  • EPS Growth
  • LEE N/A
  • CTSO N/A
  • EPS
  • LEE N/A
  • CTSO N/A
  • Revenue
  • LEE $591,094,000.00
  • CTSO $35,332,238.00
  • Revenue This Year
  • LEE N/A
  • CTSO $18.34
  • Revenue Next Year
  • LEE N/A
  • CTSO $19.82
  • P/E Ratio
  • LEE N/A
  • CTSO N/A
  • Revenue Growth
  • LEE N/A
  • CTSO 15.37
  • 52 Week Low
  • LEE $6.00
  • CTSO $0.70
  • 52 Week High
  • LEE $19.63
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • LEE 32.43
  • CTSO 67.21
  • Support Level
  • LEE $6.20
  • CTSO $1.03
  • Resistance Level
  • LEE $6.72
  • CTSO $1.29
  • Average True Range (ATR)
  • LEE 0.39
  • CTSO 0.09
  • MACD
  • LEE 0.03
  • CTSO 0.02
  • Stochastic Oscillator
  • LEE 21.00
  • CTSO 75.45

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: